MedTrace Logo

Study of Immunosuppressive Therapy Toxicities in Kidney Transplant Recipients at Regional or Satellite Community Clinics

NCT00902980 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 264

Last updated 2014-09-18

No results posted yet for this study

Summary

This is a multicentre, observational, non-interventional, retrospective analysis by chart review.

Conditions

  • Kidney Transplantation

Interventions

OTHER

Chart Review

Chart review of patients / graft outcome in renal transplant recipients

Sponsors & Collaborators

  • Astellas Pharma Canada, Inc.

    collaborator INDUSTRY

  • Astellas Pharma Inc

    lead INDUSTRY

Principal Investigators

  • Use Central Contact · Astellas Pharma Canada, Inc.

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-04-30
Primary Completion
2006-12-31
Completion
2006-12-31

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00902980 on ClinicalTrials.gov